sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH
For active pharmaceutical ingredients (APIs) related to Soluble Epoxide Hydrolase (murine recombinant from Sf21 cells), see Cayman Pharma
![]() |
![]() |
![]() |
![]() |
|
Source:
Murine recombinant N- |
|
1
Chiamvimonvat, N., Ho, C., Tsai, H., et al. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50(3) 225-
2
Yu, Z., Xu, F., Huse, L.M., et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87 992-
3
Imig, J.D., Zhao, X., Zaharis, C.Z., et al. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-
|
![]() | Download Product Insert 211 Kb PDF |
![]() | Download Material Safety Data Sheet (MSDS) 23 Kb PDF |
Prices listed here are the Manufacturer's Suggested European Retail Price. The actual prices quoted by each individual distributor may vary. Please visit the Global Buyer's Guide on the Cayman Chemical (world) website to locate a distributor in your region.
This product is also available to buy in bulk quantities. Please contact us for a quote or to purchase.
Cayman strives to be a reliable biochemical reagent vendor by providing the best possible products and services. To ask for assistance with one of our products please contact our Technical Help staff.
Warning This product is not for human or veterinary use.
|
Item total €0.00
Shopping cart total €0.00 |